128 related articles for article (PubMed ID: 10621892)
21. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
[No Abstract] [Full Text] [Related]
22. Rhabdomyolysis associated with omeprazole.
Nozaki M; Suzuki T; Hirano M
J Gastroenterol; 2004 Jan; 39(1):86. PubMed ID: 14767743
[No Abstract] [Full Text] [Related]
23. Rabeprazole-induced acute interstitial nephritis.
Geevasinga N; Coleman PL; Roger SD
Nephrology (Carlton); 2005 Feb; 10(1):7-9. PubMed ID: 15705174
[TBL] [Abstract][Full Text] [Related]
24. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
[TBL] [Abstract][Full Text] [Related]
25. Rebound hypersecretion after omeprazole.
Friedel DM; Gbadehan E
Gastroenterology; 1999 Aug; 117(2):513-4. PubMed ID: 10465638
[No Abstract] [Full Text] [Related]
26. Functional dyspepsia: bye-bye to PPIs.
Nyrén O
Gut; 2002 Oct; 51(4):464-5. PubMed ID: 12235062
[No Abstract] [Full Text] [Related]
27. Proton-pump inhibitors for acute peptic ulcer bleeding.
Erstad BL
Ann Pharmacother; 2001 Jun; 35(6):730-40. PubMed ID: 11408992
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors and iron deficiency: is the connection real?
Nand S; Tanvetyanon T
South Med J; 2004 Sep; 97(9):799. PubMed ID: 15455957
[No Abstract] [Full Text] [Related]
29. Cutaneous leucocytoclastic vasculitis associated with omeprazole.
Odeh M; Lurie M; Oliven A
Postgrad Med J; 2002 Feb; 78(916):114-5. PubMed ID: 11807212
[TBL] [Abstract][Full Text] [Related]
30. Hyperprolactinaemia induced by proton pump inhibitor.
Jabbar A; Khan R; Farrukh SN
J Pak Med Assoc; 2010 Aug; 60(8):689-90. PubMed ID: 20726208
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
Koelz HR; Arnold R; Stolte M; Fischer M; Blum AL;
Gut; 2003 Jan; 52(1):40-6. PubMed ID: 12477757
[TBL] [Abstract][Full Text] [Related]
32. Omeprazole-associated rhabdomyolysis.
Tanaka K; Nakada TA; Abe R; Itoga S; Nomura F; Oda S
Crit Care; 2014 Jul; 18(4):462. PubMed ID: 25184508
[No Abstract] [Full Text] [Related]
33. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
34. Increasing concerns about chronic proton pump inhibitor use.
Svoboda AC
J Clin Gastroenterol; 2001 Jul; 33(1):3-7. PubMed ID: 11418781
[No Abstract] [Full Text] [Related]
35. [Drug interactions. Proton pump inhibitors. 1].
Gleiter CH
Internist (Berl); 1998 Aug; 39(8):874-5. PubMed ID: 9757395
[No Abstract] [Full Text] [Related]
36. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
Leonhardt U; Ritzel U; Ramadori G
Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
[No Abstract] [Full Text] [Related]
37. Side effects of omeprazole.
Markitziu A; Aframian D
Scand J Gastroenterol; 1996 Jun; 31(6):624. PubMed ID: 8789905
[No Abstract] [Full Text] [Related]
38. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
Müller P; Fuchs W; Peifer-Weiss A; Simon B
Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
[No Abstract] [Full Text] [Related]
39. [Acid pump inhibitors and pregnancy: apropos of 24 women with known development].
Choulika S; Carlier P; Efthymiou ML
Therapie; 1997; 52(6):612-13. PubMed ID: 9734118
[No Abstract] [Full Text] [Related]
40. Hypergastrinaemia with long-term omeprazole treatment.
Bateson MC
Aliment Pharmacol Ther; 1999 Mar; 13(3):440-1. PubMed ID: 10103171
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
